Abstract

The broad clinical spectrum of bipolar disorder is under-diagnosed and may affect up to 5% of the population. In recent years, several instruments have been developed to aid screening, diagnosis and research into bipolar spectrum disorders. Here we review the strengths and limitations of these instruments, which include the Mood Disorder Questionnaire (MDQ), the Hypomania Checklist (HCL-32) and the Bipolar Spectrum Diagnostic Scale (BSDS). We focus on the potential use of these instruments in primary care and community psychiatric settings.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.